CNNE Fundamental Analysis - CANNAE HOLDINGS INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CNNE. CNNE was compared to 100 industry peers in the Financial Services industry. While CNNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CNNE does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.

In the past year CNNE has reported a negative cash flow from operations.

CNNE had negative earnings in 4 of the past 5 years.

In the past 5 years CNNE always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of CNNE (-15.63%) is worse than 92.00% of its industry peers.

CNNE has a worse Return On Equity (-19.05%) than 88.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-15.63%
ROE	-19.05%
ROIC	N/A

ROA(3y)-13.01%

ROA(5y)-1.54%

ROE(3y)-15.27%

ROE(5y)-1.43%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CNNE's Gross Margin of 17.30% is on the low side compared to the rest of the industry. CNNE is outperformed by 60.00% of its industry peers.

CNNE's Gross Margin has improved in the last couple of years.

CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.3%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.75%

GM growth 5Y3.28%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CNNE has less shares outstanding

The number of shares outstanding for CNNE has been reduced compared to 5 years ago.

Compared to 1 year ago, CNNE has a worse debt to assets ratio.

2.2 Solvency

CNNE has an Altman-Z score of 2.86. This is not the best score and indicates that CNNE is in the grey zone with still only limited risk for bankruptcy at the moment.

CNNE has a Altman-Z score of 2.86. This is amongst the best in the industry. CNNE outperforms 82.00% of its industry peers.

A Debt/Equity ratio of 0.04 indicates that CNNE is not too dependend on debt financing.

With an excellent Debt to Equity ratio value of 0.04, CNNE belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	2.86

ROIC/WACCN/A

WACC8.53%

2.3 Liquidity

A Current Ratio of 4.19 indicates that CNNE has no problem at all paying its short term obligations.

CNNE has a Current ratio of 4.19. This is amongst the best in the industry. CNNE outperforms 88.00% of its industry peers.

A Quick Ratio of 4.19 indicates that CNNE has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 4.19, CNNE belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	4.19
Quick Ratio	4.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.31% over the past year.

The Revenue for CNNE has decreased by -15.46% in the past year. This is quite bad

The Revenue for CNNE have been decreasing by -15.81% on average. This is quite bad

EPS 1Y (TTM)3.31%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-42.52%

Revenue 1Y (TTM)-15.46%

Revenue growth 3Y-15.21%

Revenue growth 5Y-15.81%

Sales Q2Q%-6.78%

3.2 Future

The Earnings Per Share is expected to grow by 32.10% on average over the next years. This is a very strong growth

Based on estimates for the next years, CNNE will show a decrease in Revenue. The Revenue will decrease by -1.19% on average per year.

EPS Next Y42.19%

EPS Next 2Y32.1%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-4.32%

Revenue Next 2Y-1.19%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CNNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNNE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 32.10% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y32.1%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 2.26%. Purely for dividend investing, there may be better candidates out there.

CNNE's Dividend Yield is a higher than the industry average which is at 4.86.

Compared to an average S&P500 Dividend Yield of 2.35, CNNE has a dividend comparable with the average S&P500 company.

		Industry Rank	Sector Rank
Dividend Yield	2.26%

5.2 History

CNNE has been paying a dividend for less than 5 years, so it still needs to build a track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

The earnings of CNNE are negative and hence is the payout ratio. CNNE will probably not be able to sustain this dividend level.

DP-9.15%

EPS Next 2Y32.1%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CANNAE HOLDINGS INC

NYSE:CNNE (7/15/2025, 8:04:00 PM)

After market: 21.43 0 (0%)

21.43

-0.21 (-0.97%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryFinancial Services

Earnings (Last)05-12 2025-05-12/amc

Earnings (Next)08-06 2025-08-06/amc

Inst Owners87.49%

Inst Owner Change0%

Ins Owners10.37%

Ins Owner Change0.41%

Market Cap1.35B

Analysts85

Price Target22.44 (4.71%)

Short Float %5.25%

Short Ratio3.94

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.26%

Yearly Dividend0.34

Dividend Growth(5Y)N/A

DP-9.15%

Div Incr Years0

Div Non Decr Years0

Ex-Date06-16 2025-06-16 (0.12)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-243.65%

Min EPS beat(2)-339.96%

Max EPS beat(2)-147.33%

EPS beat(4)1

Avg EPS beat(4)-448.81%

Min EPS beat(4)-1308.4%

Max EPS beat(4)0.45%

EPS beat(8)1

Avg EPS beat(8)-768.22%

EPS beat(12)3

Avg EPS beat(12)-609.94%

EPS beat(16)4

Avg EPS beat(16)-1263.95%

Revenue beat(2)1

Avg Revenue beat(2)-1.09%

Min Revenue beat(2)-3.92%

Max Revenue beat(2)1.74%

Revenue beat(4)3

Avg Revenue beat(4)1.7%

Min Revenue beat(4)-3.92%

Max Revenue beat(4)5.68%

Revenue beat(8)3

Avg Revenue beat(8)-4.92%

Revenue beat(12)3

Avg Revenue beat(12)-6.74%

Revenue beat(16)4

Avg Revenue beat(16)-5.61%

PT rev (1m)0%

PT rev (3m)-10.81%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-5.19%

EPS NY rev (1m)-3.41%

EPS NY rev (3m)-134.65%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-3.1%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-2.62%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.03
P/FCF	N/A
P/OCF	N/A
P/B	0.78
P/tB	0.81
EV/EBITDA	N/A

EPS(TTM)-5.26

EYN/A

EPS(NY)-1.2

Fwd EYN/A

FCF(TTM)-0.84

FCFYN/A

OCF(TTM)-0.72

OCFYN/A

SpS7.08

BVpS27.38

TBVpS26.3

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.63%
ROE	-19.05%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.3%
FCFM	N/A

ROA(3y)-13.01%

ROA(5y)-1.54%

ROE(3y)-15.27%

ROE(5y)-1.43%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.75%

GM growth 5Y3.28%

F-Score4

Asset Turnover0.21

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	58.02%
Cap/Sales	1.71%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.19
Quick Ratio	4.19
Altman-Z	2.86

F-Score4

WACC8.53%

ROIC/WACCN/A

Cap/Depr(3y)55.99%

Cap/Depr(5y)58.5%

Cap/Sales(3y)1.82%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.31%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-42.52%

EPS Next Y42.19%

EPS Next 2Y32.1%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-15.46%

Revenue growth 3Y-15.21%

Revenue growth 5Y-15.81%

Sales Q2Q%-6.78%

Revenue Next Year-4.32%

Revenue Next 2Y-1.19%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y38.23%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year49.17%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y73.58%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y75.85%

OCF growth 3YN/A

OCF growth 5YN/A

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens